Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, May 15, 2015, 111 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,266.50 to $281,749,912.50.

Highlighted Stocks Traded by Insiders:

Two Harbors Investment (TWO) - FREE Research Report

Farrell Brad, who is CFO and Treasurer at Two Harbors Investment, sold 37,969 shares at $10.47 on May 15, 2015. Following this transaction, the CFO and Treasurer owned 129,043 shares meaning that the stake was reduced by 22.73% with the 37,969-share transaction.

The shares most recently traded at $10.58, up $0.11, or 1.06% since the insider transaction. Historical insider transactions for Two Harbors Investment go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 45,660
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 45,660
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 45,660

The average volume for Two Harbors Investment has been 3.0 million shares per day over the past 30 days. Two Harbors Investment has a market cap of $3.9 billion and is part of the financial sector and real estate industry. Shares are up 5.39% year-to-date as of the close of trading on Friday.

Two Harbors Investment Corp. The stock currently has a dividend yield of 9.88%. The company has a P/E ratio of 13.2. Currently, there are 10 analysts who rate Two Harbors Investment a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on TWO - FREE

TheStreet Quant Ratings rates Two Harbors Investment as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, attractive valuation levels and expanding profit margins. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Two Harbors Investment Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Nutraceutical International (NUTR) - FREE Research Report

Neuberger Christopher B, who is VP, Sales & Marketing at Nutraceutical International, sold 1,500 shares at $19.08 on May 15, 2015. Following this transaction, the VP, Sales & Marketing owned 9,471 shares meaning that the stake was reduced by 13.67% with the 1,500-share transaction.

The shares most recently traded at $20.00, up $0.92, or 4.58% since the insider transaction. Historical insider transactions for Nutraceutical International go as follows:

  • 4-Week # shares bought: 1,400
  • 12-Week # shares bought: 1,400
  • 24-Week # shares bought: 1,400

The average volume for Nutraceutical International has been 16,500 shares per day over the past 30 days. Nutraceutical International has a market cap of $193.4 million and is part of the consumer goods sector and food & beverage industry. Shares are down 6.91% year-to-date as of the close of trading on Friday.

Nutraceutical International Corporation manufactures, markets, distributes, and retails branded nutritional supplements and other natural products in the United States and internationally. The company has a P/E ratio of 13.2. Currently, there is 1 analyst who rates Nutraceutical International a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NUTR - FREE

TheStreet Quant Ratings rates Nutraceutical International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Nutraceutical International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Silgan Holdings (SLGN) - FREE Research Report

Snyder Thomas James, who is President - Silgan Containers at Silgan Holdings, sold 4,063 shares at $54.65 on May 15, 2015. Following this transaction, the President - Silgan Containers owned 63,560 shares meaning that the stake was reduced by 6.01% with the 4,063-share transaction.

The shares most recently traded at $55.84, up $1.19, or 2.13% since the insider transaction. Historical insider transactions for Silgan Holdings go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 2,271
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 114,230
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 117,998

The average volume for Silgan Holdings has been 256,100 shares per day over the past 30 days. Silgan Holdings has a market cap of $3.3 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 3.96% year-to-date as of the close of trading on Friday.

Silgan Holdings Inc., together with its subsidiaries, manufactures and sells rigid packaging for shelf-stable food and other consumer goods products worldwide. The company operates through three segments: Metal Containers, Closures, and Plastic Containers. The stock currently has a dividend yield of 1.16%. The company has a P/E ratio of 19.0. Currently, there are no analysts who rate Silgan Holdings a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SLGN - FREE

TheStreet Quant Ratings rates Silgan Holdings as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, notable return on equity and growth in earnings per share. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Silgan Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.